• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$20.12 -$0.04 (-0.20%)

REAL-TIME: Last trade at

ViroPharma, Inc.

NASDAQ:VPHM

4 Highly Liquid Biotech Stocks Being Snapped Up By Insiders

Investing 101: Biotech Stocks With Insider Buying

Abbott Stands Up to Obamacare

ViroPharma Falters, Guides Lower - Analyst Blog

Are Supply Troubles a Biotech Buying Opportunity?

ViroPharma down 11% on results

Why ViroPharma Shares Got Pummeled

ViroPharma Misses on Both Revenue and Earnings

The Big Bet on Protalix

Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeut

Something to Watch at ViroPharma

ViroPharma Inks Deal with Prasco - Analyst Blog

5 of Last Week's Biggest Losers

The Week's Biggest Stock Disappointments

Why Did These Stocks Just Die?

Is Halozyme the Perfect Stock?

FDA Upsets ViroPharma - Analyst Blog

With Revenue Decimated, Is ViroPharma a Buy?

Tuesday’s biggest gaining and declining stocks

VioPharma Runs Into FDA & FTC Troubles Over Staph Drug (VPHM)

ViroPharma sinks 19% on business update

Why ViroPharma Shares Imploded

ViroPharma Drops on FTC Probe, Generic Drug Rival

Why ViroPharma May Be About to Take Off

VPHM-HALO Report Encouraging Data - Analyst Blog

ViroPharma's Cinryze Reaches UK - Analyst Blog

ViroPharma Beats; All Set to Shine - Analyst Blog

ViroPharma Beats Up on Analysts Yet Again

ViroPharma Reports Encouraging Data - Analyst Blog

ViroPharma Extends Buccolam's Reach - Analyst Blog

Make Money in Rapidly Growing Small Caps the Easy Way

Update on VPHM's Industrial Facility - Analyst Blog

US STOCK FUTURES: HOT STOCKS TO WATCH

The Fastest Growers in Pharma

Is ViroPharma's Growth for Real?

Priority Review for VPHM's Drug - Analyst Blog

Optimer Buoyant on Difficid Sales - Analyst Blog

Company News for January 9, 2012 - Corporate Summary

US Stock Futures: HOT STOCKS TO WATCH

ViroPharma Expects a Strong 2012 - Analyst Blog

See More Articles...